GASTRICHIP : D2 Resection and HIPEC (Hyperthermic Intraperitoneal Chemoperfusion) in Locally Advanced Gastric Carcinoma. A Randomized and Multicentric Phase III Study
Phase of Trial: Phase III
Latest Information Update: 05 Jun 2017
At a glance
- Drugs Oxaliplatin (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- Acronyms GASTRICHIP
- 20 Jan 2016 Planned End Date changed from 1 May 2021 to 1 May 2023 as reported by ClinicalTrials.gov.
- 20 Jan 2016 Planned primary completion date changed from 1 May 2021 to 1 May 2023 as reported by ClinicalTrials.gov.
- 13 Jul 2013 New trial record